RECRUITING

Veteran's Perceptions of Ketamine-Assisted Psychotherapy for Depression and End-of-Life

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of this exploratory, mixed-method design study is to gather qualitative and quantitative data obtained through interviews and questionnaires with veterans who are currently enrolled at the VA for healthcare. The main question this study aims to answer is: How do veterans aged 65+ who are enrolled for care at the VA understand ketamine assisted psychotherapy for depression and for end-of-life distress? Using a story-completion approach, participants will be provided with a brief story starter involving a fictitious character and scenario and asking them to complete the story. Few contextual details will be offered about the character. In responding to ambiguous cues, participants are thought to project their conscious and subconscious perceptions about the phenomenon in question onto the story, a useful method for exploring stigmatized topics. The purpose of this exercise is to ascertain the participants attitudes and perceptions regarding ketamine assisted psychotherapy.

Official Title

Veteran's Perceptions of Ketamine-Assisted Psychotherapy (KAP) for Depression and End-of-Life

Quick Facts

Study Start:2024-11-08
Study Completion:2025-04
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06824532

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:65 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Veterans enrolled in VA care.
  2. * Age 65 or older.
  3. * Fluent in written and spoken English.
  1. * Cognitively impaired to the extent that patient cannot comprehend the survey.

Contacts and Locations

Study Contact

Caitlin Holley, Ph.D.
CONTACT
518-626-5365
caitlin.holley@va.gov
Stacey Farmer, Ph.D.
CONTACT
518-798-6066
stacey.farmer@va.gov

Principal Investigator

Caitlin Holley, Ph.D.
PRINCIPAL_INVESTIGATOR
Albany Research Institute, Inc.

Study Locations (Sites)

Stratton VA Medical Center
Albany, New York, 12208
United States

Collaborators and Investigators

Sponsor: Albany Research Institute, Inc.

  • Caitlin Holley, Ph.D., PRINCIPAL_INVESTIGATOR, Albany Research Institute, Inc.

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-11-08
Study Completion Date2025-04

Study Record Updates

Study Start Date2024-11-08
Study Completion Date2025-04

Terms related to this study

Additional Relevant MeSH Terms

  • Depression